JPMorgan lowered the firm's price target on Exponent to $80 from $95 and keeps an Overweight rating on the shares. The firm adjusted ratings and targets in the smaller cap industrials group post the Q1 reports. As macro uncertainty continues, JPMorgan emphasizes "selectivity and a focus on resilient end-markets and visible growth drivers," the analyst tells investors in a research note.
